Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Challenges of Suicide Outcomes Ascertainment in Administrative Claims Databases.

Pennap DD, Mosholder AD, Swain RS.

JAMA Psychiatry. 2019 Sep 4. doi: 10.1001/jamapsychiatry.2019.2338. [Epub ahead of print] No abstract available.

PMID:
31483450
2.

Antipsychotic Use and Stroke: A Retrospective Comparative Study in a Non-Elderly Population.

Taylor LG, Panucci G, Mosholder AD, Toh S, Huang TY.

J Clin Psychiatry. 2019 Jun 4;80(4). pii: 18m12636. doi: 10.4088/JCP.18m12636.

PMID:
31163104
3.

Re: "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial" by Findling et al. (J Child Adolesc Psychopharmacol 2019;29:80-89).

Mosholder AD, Kim J, Davis M, Farchione TR.

J Child Adolesc Psychopharmacol. 2019 Nov;29(9):725. doi: 10.1089/cap.2019.0061. Epub 2019 May 16. No abstract available.

PMID:
31094581
4.

A systematic review of validated suicide outcome classification in observational studies.

Swain RS, Taylor LG, Braver ER, Liu W, Pinheiro SP, Mosholder AD.

Int J Epidemiol. 2019 Oct 1;48(5):1636-1649. doi: 10.1093/ije/dyz038.

PMID:
30907424
5.

Overall and cause-specific mortality in the Sentinel system: A power analysis.

Swain RS, Taylor LG, Woodworth TS, Fuller CC, Petrone AB, Menzin TJ, Haug NR, Toh S, Mosholder AD.

Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1416-1421. doi: 10.1002/pds.4692. Epub 2018 Nov 13.

PMID:
30421839
6.

Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs".

Suggs CM, Levin RL, Mosholder AD, Swain RS, Zhao L.

Drug Saf. 2018 Dec;41(12):1419-1421. doi: 10.1007/s40264-018-0726-3. No abstract available.

PMID:
30232739
7.

Incidence of Heart Failure and Cardiomyopathy Following Initiation of Medications for Attention-Deficit/Hyperactivity Disorder: A Descriptive Study.

Mosholder AD, Taylor L, Mannheim G, Ortendahl L, Woodworth TS, Toh S.

J Clin Psychopharmacol. 2018 Oct;38(5):505-508. doi: 10.1097/JCP.0000000000000939.

PMID:
30102629
8.

Long-Term Risk of Acute Myocardial Infarction, Stroke, and Death With Outpatient Use of Clarithromycin: A Retrospective Cohort Study.

Mosholder AD, Lee JY, Zhou EH, Kang EM, Ghosh M, Izem R, Major JM, Graham DJ.

Am J Epidemiol. 2018 Apr 1;187(4):786-792. doi: 10.1093/aje/kwx319.

PMID:
29036565
9.

A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch.

Cunningham FE, Hur K, Dong D, Miller DR, Zhang R, Wei X, McCarren M, Mosholder AD, Graham DJ, Aspinall SL, Good CB.

Addiction. 2016 Jul;111(7):1283-92. doi: 10.1111/add.13329. Epub 2016 Apr 15.

PMID:
26826702
10.

Nonsteroidal Anti-Inflammatory Drug and Aspirin Use, and Mortality among Critically Ill Pandemic H1N1 Influenza Patients: an Exploratory Analysis.

Epperly H, Vaughn FL, Mosholder AD, Maloney EM, Rubinson L.

Jpn J Infect Dis. 2016 May 20;69(3):248-51. doi: 10.7883/yoken.JJID.2014.577. Epub 2015 Aug 7.

11.

Reservations about study on antidepressant use by young people and suicidal behaviour after FDA warnings.

Mosholder AD, Taylor LG, Crentsil V.

BMJ. 2014 Oct 29;349:g6503. doi: 10.1136/bmj.g6503. No abstract available.

PMID:
25355684
12.

Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries.

Mosholder AD, Racoosin JA, Young S, Wernecke M, Shoaibi A, MaCurdy TE, Worrall C, Kelman JA.

Ann Pharmacother. 2013 Nov;47(11):1420-8. doi: 10.1177/1060028013500940.

PMID:
24285759
13.

Cardiovascular risks with azithromycin.

Mosholder AD, Nambiar S.

N Engl J Med. 2013 Aug 8;369(6):581. doi: 10.1056/NEJMc1306999. No abstract available.

PMID:
23930274
14.

Cardiovascular risks with azithromycin and other antibacterial drugs.

Mosholder AD, Mathew J, Alexander JJ, Smith H, Nambiar S.

N Engl J Med. 2013 May 2;368(18):1665-8. doi: 10.1056/NEJMp1302726. No abstract available.

15.

Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.

Meyer TE, Taylor LG, Xie S, Graham DJ, Mosholder AD, Williams JR, Moeny D, Ouellet-Hellstrom RP, Coster TS.

Addiction. 2013 Jan;108(1):203-10. doi: 10.1111/j.1360-0443.2012.04024.x. Epub 2012 Oct 18.

PMID:
22812921
16.

Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists.

McMahon AW, Levenson MS, McEvoy BW, Mosholder AD, Murphy D.

Pediatrics. 2011 Nov;128(5):e1147-54. doi: 10.1542/peds.2010-1720. Epub 2011 Oct 24. Review.

PMID:
22025595
17.

Suicide and antidepressants. Beware extrapolation from ecological data.

Hammad TA, Mosholder AD.

BMJ. 2010 Nov 30;341:c6844. doi: 10.1136/bmj.c6844. No abstract available.

PMID:
21118884
18.

Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.

Pamer CA, Hammad TA, Wu YT, Kaplan S, Rochester G, Governale L, Mosholder AD.

Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):158-74. doi: 10.1002/pds.1886.

PMID:
20049836
19.

Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.

Gish P, Mosholder AD, Truffa M, Johann-Liang R.

J Pediatr. 2009 Sep;155(3):432-4. doi: 10.1016/j.jpeds.2009.01.074.

PMID:
19732583
20.

Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.

Mosholder AD, Gelperin K, Hammad TA, Phelan K, Johann-Liang R.

Pediatrics. 2009 Feb;123(2):611-6. doi: 10.1542/peds.2008-0185. Review.

PMID:
19171629
21.

Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants.

Mosholder AD, Pamer CA.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):33-6.

PMID:
16553527
22.
23.

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs.

Phelan KM, Mosholder AD, Lu S.

J Clin Psychiatry. 2003 Nov;64(11):1328-34. Review.

PMID:
14658947

Supplemental Content

Loading ...
Support Center